0
Article |

Dose Response of Subcutaneous Terbutaline and Epinephrine in Children With Acute Asthma FREE

F. Estelle R. Simons, MD; John D. Gillies, MB, ChB
[+] Author Affiliations

Reprint requests to Department of Pediatrics, University of Manitoba, 685 Bannatyne Ave, Winnipeg, Manitoba, Canada R3E 0W1 (Dr Simons).


Am J Dis Child. 1981;135(3):214-217. doi:10.1001/archpedi.1981.02130270006004.
Text Size: A A A
Published online

• In a double-blind dose response study in 26 children, 3, 6, or 12 μg/kg of terbutaline sulfate was compared with 10 μg/kg of epinephrine administered subcutaneously. In the first hour after subtion, all doses of terbutaline and epinephrine resulted in improvement in mean clinical score, mean forced vital capacity, mean forced expiratory volume in the first second, and mean forced expiratory flow from 25% to 75% of vital capacity. Terbutaline was not significantly more effective than epinephrine. However, while adverse effects following terbutaline were clinically imperceptible, epinephrine produced unpleasant headache and excitement in a few patients. Terbutaline did not change mean PaO2 or PaCO2 significantly in a subgroup of patients. The 12 μg/kg dose of terbutaline was superior to 3 or 6 μg/kg in relieving obstruction to airflow measured at the midportion of the vital capacity. This dose caused tremor in some children, but the tremor was not apparent to patients or their parents.

(Am J Dis Child 1981;135:214-217)

REFERENCES

Davis WJ, Pang LM, Chernack WJ, et al:  Terbutaline in the treatment of acute asthma in childhood . Chest 1977;;72:614-617.
Sly RM, Badiei B, Faciane J:  Comparison of subcutaneous terbutaline with epinephrine in the treatment of asthma in children . J Allergy Clin Immunol 1977;;59:128-135.
Hansing B, Kjellman B:  The effect of a new sympathomimetic β-receptor stimulating agent, terbutaline, given subcutaneously to asthmatic children . Acta Allergol 1972;;27:130-136.
Kusoffsky E, Kraepelien S:  Terbutaline subcutaneously injected for the treatment of bronchial asthma in children . Acta Allergol 1974;;29:256-260.
Koivikko A:  A comparison of the effects of subcutaneous orciprenaline, salbutamol and terbutaline in asthmatic children . Ann Clin Res 1974;;6:99-104.
Shapiro GG, Simons FE, Pierson WE, et al:  The management of status asthmaticus in children , in Smith CA (ed): The Critically Ill Child: Diagnosis and Management . Philadelphia, WB Saunders Co, 1977;, pp 178-193.
Lindquist EF: Design and Analysis of Experiments . Boston, Houghton Mifflin Co, 1956;, p 266.
Pang LM, Rodriguez-Martinez F, Davis WJ, et al:  Terbutaline in the treatment of status asthmaticus . Chest 1977;; 72:469-473.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Davis WJ, Pang LM, Chernack WJ, et al:  Terbutaline in the treatment of acute asthma in childhood . Chest 1977;;72:614-617.
Sly RM, Badiei B, Faciane J:  Comparison of subcutaneous terbutaline with epinephrine in the treatment of asthma in children . J Allergy Clin Immunol 1977;;59:128-135.
Hansing B, Kjellman B:  The effect of a new sympathomimetic β-receptor stimulating agent, terbutaline, given subcutaneously to asthmatic children . Acta Allergol 1972;;27:130-136.
Kusoffsky E, Kraepelien S:  Terbutaline subcutaneously injected for the treatment of bronchial asthma in children . Acta Allergol 1974;;29:256-260.
Koivikko A:  A comparison of the effects of subcutaneous orciprenaline, salbutamol and terbutaline in asthmatic children . Ann Clin Res 1974;;6:99-104.
Shapiro GG, Simons FE, Pierson WE, et al:  The management of status asthmaticus in children , in Smith CA (ed): The Critically Ill Child: Diagnosis and Management . Philadelphia, WB Saunders Co, 1977;, pp 178-193.
Lindquist EF: Design and Analysis of Experiments . Boston, Houghton Mifflin Co, 1956;, p 266.
Pang LM, Rodriguez-Martinez F, Davis WJ, et al:  Terbutaline in the treatment of status asthmaticus . Chest 1977;; 72:469-473.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.